Filed before 2025Filed 7 April 2014
Daktari Diagnostics, Inc. has sold $20M so far
Daktari Diagnostics, Inc., a biotech company based in Cambridge, MA, has sold $20M so far in its equity round, according to a filing dated 7 April 2014.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 April 2014
- Round
- Equity round (amended filing)
- Amount sold
- $20M
- Offering size
- $20M
- Investors so far
- 27
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 81% of the 1,533 tracked raises with an amount filed in 2014, and than 75% of the 109 in biotech.
Daktari Diagnostics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 25 May 2016 | Amended filing | $22.5M | Another raise |
| 13 Mar 2015 | New filing | $15.5M | Another raise |
| 7 Apr 2014 | Amended filing | $20M | This raise |
More with Partners Innovation on the board
- Claris Biotherapeutics, Inc.$55.7M
- CodaMetrix Inc.$11.6M
- Mediar Therapeutics, Inc.$85M
- SeQure Dx Inc.$2.18M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.